Alpine Immune Sciences (ALPN) Tops Q1 EPS by 14c

Alpine Immune Sciences (NASDAQ: ALPN) reported Q1 EPS of ($0.28), $0.14 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $7.03 million versus the consensus estimate of $3.52 million.

For earnings history and earnings-related data on Alpine Immune Sciences (ALPN) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Pan American Silver (PAAS) Misses Q2 EPS by 19c
• Nortech Systems, Inc. (NSYS) Tops Q2 EPS by 11c